Syrian medics will purchase cancer drugs in Beshenkovichi

Syria is interested in the supply of anti-tumor drugs manufactured by Nativita LLC, and is also ready to consider options for establishing similar production in the country with the participation of foreign investors.

This was discussed during the recent visit of an official delegation from the Ministry of Health of Syria, led by Minister Nizar Wahbe Yaziji, to the Beshenkovichi-based enterprise. According to Alena Maryanskaya, Public Relations Manager at the pharmaceutical manufacturer, the Middle Eastern guests were acquainted with Nativita's production capabilities. During the negotiations, the head of the Syrian delegation highly praised the company's potential and expressed interest in purchasing medicines for the needs of Syrian healthcare institutions.

Alexey Sychev, Chairman of the Board of Directors of Nativita, noted that the Syrian market is a priority for the company, and all necessary documents for the registration of medicines there will be submitted in the near future. To consolidate the agreements reached and form a cooperation roadmap, Mr. Nizar Wahbe Yaziji invited the management of the Beshenkovichi company to visit Damascus at the end of the current year and participate in a business forum, the main theme of which will be the development of the pharmaceutical industry in Syria.

A separate topic of negotiations was the discussion of the possibility of creating similar production in Syria. The Minister is ready to assist in the implementation of such a project. Cooperation options will be discussed with Syrian companies interested in partnership.

By 2020, the export volume of Nativita LLC is projected to be at the level of
50 million euros.

Sergey Antonov, "Vitebskiye Vesti". Photos from open sources.